🇨🇦 Combination of low ICS and montelukast in Canada

Combination of low ICS and montelukast (Combination of low ICS and montelukast) regulatory status in Canada.

Marketing authorisation

Combination of low ICS and montelukast in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Combination of low ICS and montelukast approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Combination of low ICS and montelukast in Canada?

Ajou University School of Medicine is the originator. The local marketing authorisation holder may differ — check the official source linked above.